BCHE and Alzheimer disease: From the available evidence, cholinesterase inhibitors like donepezil, galantamine, rivastigmine and Hup-A, showed symptomatic benefits in AD that could improve cognitive performance and global functioning [13, 64], though the brain damage was not terminated [65].